Introduction {#sec1-1}
============

The genus Ferula belongs to the family Apiaceae. The family Apiaceae consists of flowering and usually aromatic plants that mostly grow in temperate areas and are distributed throughout the Mediterranean region and central Asia ([@ref1]). 300 Genera and 3000 species of this family have been explored worldwide. In Iranian flora, the family Apiaceae consists of 112 genera, 316 species and 75 endemic plant species. In Iran, the genus Ferula contains 30 species including 15 endemic plants ([@ref2]). Several species of this genus have been used in traditional medicine for the treatment of various organ disorders. In Iran, *Ferula* species are typically called koma or kema ([@ref2]). *Ferula persica* ([Figure 1](#F1){ref-type="fig"}) is the well-known species of the genus Ferula that is traditionally used as laxative, carminative, anti-hysteric, and for the treatment of diabetes, rheumatism and backache ([@ref3]). The plant with stout, hollow, somewhat succulent stems reaching up to 1 m in height and yellow flowers, is endemic to Iran, Turkey and Afghanistan. The chemical constituents from *F. persica* include volatile compounds ([@ref3], [@ref4]), sesquiterpene coumarins ([@ref5], [@ref6]), sulfur-containing compounds ([@ref7]-[@ref10]), and sesquiterpene coumarin glycosides ([Figure 2](#F2){ref-type="fig"}) ([@ref11]). *F. persica* contains biologically active sesquiterpene coumarins including umbelliprenin ([@ref1]), farnesiferols A ([@ref2]) and B ([@ref3]). Umbelliprenin has shown anti-inflammatory ([@ref12]), apoptotic ([@ref13], [@ref14]) and anti-pigmentation ([@ref15]) properties. Farnesiferols A and B indicated reversal of multi-drug resistance ([@ref16], [@ref17]) and cytotoxic properties ([@ref13]).

![The plant *Ferula persica*](IJBMS-20-1-g001){#F1}

![Chemical constituents from *Ferula persica*](IJBMS-20-1-g002){#F2}

In this paper, we aimed to highlight phytochemicals and pharmacological effects of F. persica and discussed about the potential effects of the plant and its constituents that deserve future research.

All relevant databases were searched for the terms "*F. persica*" and the names of its chemical constituents including "umbelliprenin", "auraptene", "farnesiferols A, B and C" and "sesquiterpene coumarins" without limitation up to April 2016. Information on the mentioned terms was collected via electronic search using Pubmed, Scopus, Web of Science and SID (for articles in Persian language), and local books on ethnopharmacology.

Phytochemistry {#sec2-1}
--------------

*Ferula* species are rich sources of sesquiterpene coumarins ([@ref5], [@ref18]), sesquiterpenes ([@ref19]), sesquiter-pene coumarin glycosides ([@ref5], [@ref11]) and sulfur containing compounds ([@ref7], [@ref9]). To date, promising bioactive compounds such as auraptene ([@ref20]-[@ref23]) (antihypertensive, anti-inflammatory and cancer chemopreventive), umbelliprenin ([@ref12], [@ref23]-[@ref25]) (anti-inflammatory and cancer chemopreventive), and galbanic acid ([@ref26]) (anti-tumor and anti-angiogenic) have been reported from *Ferula* species.

Sesquiterpenes and sesquiterpene coumarins {#sec2-2}
------------------------------------------

Tsukevanik *et al* was the first group to begin to investigate plants of the genus *Ferula* in 1935 ([@ref5]). *Ferula* is a genus rich of coumarins, particularly sesquiterpene coumarins ([@ref5]). Sesquiterpene deriva-tives, especially sesquiterpene coumarins, are stored in the roots of the plant, therefore the roots are a better source for isolating sesquiterpene coumarins compared to the aerial parts. The chemical constituents of plants in the genus *Ferula* have been studied by many research groups. Studies showed that *F. persica* contains sesquiterpene coumarins and sulfur compounds (volatile and non-volatile) as main constituents.

In [Figure 1](#F1){ref-type="fig"}, the chemical constituents from *F. persica* that have been reported to date ([@ref18]) are depicted. Sesquiterpene coumarins isolated from the roots of *F. persica* include umbelliprenin (**1**), farnesiferol A (**2**), farnesiferol B (**3**), badrakemone (**4**), gummosin (**5**) and farnesiferone A (Mogoltadone, **6**).

In addition, badrakemone (**4**), farnesiferone A (**6**) ([@ref18]) farnesiferol A (**2**) and a sesquiterpene with a germacrene structure (9-0-acetyl-8-0-tigloyltovarol, 7) were isolated from the aerial parts ([@ref19]). Recently, Iranshahi *et al* have also reported sesquiterpene coumarin glycosides including persicaosides A-D (**11**-**14**) from the roots of *F. persica* ([@ref11]).

Sulfur-containing compounds and volatile constituents of F. persica compounds {#sec2-3}
-----------------------------------------------------------------------------

Sulfur- containing compounds play an important role in the odor and taste of *F*. *persica*. Three major sulfur constituents that have been identified in *F. persica* ([Figure 1](#F1){ref-type="fig"}) include persicasulfide A (**8**), persicasulfide B (**9**) and persicasulfide C (**10**) ([@ref9]). To date, two studies have focused on the chemical composition of the volatile oil of *F. persica* which is also known as the synonym name of *Peucedanum persicum* ([@ref4]). In one study on the aerial parts of this plant from Iran, sixty-one components amounting to 93.7% of the total oil were identified ([Table 1](#T1){ref-type="table"}) with the essential oil yield being 0.2% v/w ([@ref27]). In another study on the root oil of *F. persica* from Iran, thirty-nine compounds comprising 82.0% of the oil were characterized ([Table 2](#T2){ref-type="table"}) ([@ref28]). Unlike the oil from aerial parts, sulfur compounds (28.6%) were the major group of compounds present in the root oil.

###### 

The chemical composition of *Ferula persica* aerial parts and its main components

  Chemical composition         \%         Main components                                        Reference
  ---------------------------- ---------- ------------------------------------------------------ ------------
  Essential oil                0.2% v/w   Dill-apiole, elemicin, limonene, 6-camphenol acetate   ([@ref27])
  Phenylpropanoids             64.7%                                                             
  Oxygenated monoterpenes      13.0%                                                             
  Monoterpene hydrocarbons     6.7%                                                              
  Sesquiterpene hydrocarbons   3.6%                                                              
  Oxygenated sesquiterpenes    0.8%                                                              

###### 

The chemical composition of *Ferula persica* root and its main components

  Chemical composition         \%         Main components                                                                                                                               Reference
  ---------------------------- ---------- --------------------------------------------------------------------------------------------------------------------------------------------- ------------
  Essential oil                0.15%v/w   Dimethyl trisulphide, dimethyl tetrasulphide, α-barbatene, lavandulyl 2-methyl butanoate, α-terpinyl isopentanoate, α-terpinyl n-pentanoate   ([@ref28])
  Sulfur compounds             28.6%                                                                                                                                                    
  Oxygenated monoterpenes      23.2%                                                                                                                                                    
  Sesquiterpene hydrocarbons   11.1%                                                                                                                                                    

The essential oil has been studied in only a few species of the genus *Ferula* and some of them include sulfur-containing compounds. Javidnia *et al* ([@ref27]) investigated the chemical composition of *F. persica* essential oil that was obtained from the aerial parts ([Table 1](#T1){ref-type="table"}). The main components of the oil were dill-apiole (57.3%) and elemicine (5.6%). Iranshahi *et al* in 2005 ([@ref28]) also reported volatile sulfur-containing compounds in the essential oil of the root of *F. persica* ([Table 2](#T2){ref-type="table"}). Dimethyl trisulphide (18.2%), myristicin (8.9%) and dimethyl tetrasulphide (7.6%) were the main volatile sulfur-containing components.

Pharmacological and biological effects {#sec2-4}
--------------------------------------

*F. persica* traditionally used as laxative, carmina-tive, anti-hysteric, and for the treatment of diabetes, rheumatism and backache ([@ref3]). The other biological properties reported from this plant include anti-inflammatory, antimicrobial and cytotoxic properties. In Table 3, we summarized biological properties of *F. persica* that have been studied yet in details. In the following, we have reported the most important biological activities from *F. persica* and its constituents to date.

Cytotoxic properties {#sec2-5}
--------------------

In 2010, Bagheri *et al* ([@ref29]) evaluated cytotoxicity and anticonvulsant activity of methanol extracts from several *Ferula* species. Their results revealed all tested methanol *Ferula* extracts, especially *F. latisecta* roots, to possess cytotoxic activity. Hajimehdipoor *et al* in 2012 investigated the cytotoxic effects of *F. persica* against tumor cell lines MCF7, HepG2, A549, HT29, and a normal cell line MDBK using the MTT method ([@ref30]). Their results showed that hexane and chloroform fractions of the plants have cytotoxic activities up to the concentration of 100 µg/ml. They showed that the extracts of *F. persica* are more cytotoxic on the cancer cell lines than *F. hezarlalezarica* (IC~50~ values, 22.3-71.8 µg/ml for *F. persica* and 76.7-105.3 µg/ml for *F. hezarlalezarica*) ([@ref30]).

Metastatic malignant melanoma has a bad prognosis mainly due to the development of lung, hepatic and brain metastases. Barthomeuf *et al* in 2008 ([@ref14]) used the resazurin reduction test and FACS analysis to evaluate the cytotoxic effects of umbelliprenin (**1**) on cancer cells and primary fibroblasts. They observed that cell susceptibility to umbelliprenin (**1**) decreases in the order M4Beu \>A549 ≈ PC3 (androgen-resistant prostate carcinoma) \>PA1 \> human primary fibroblasts ≈ MCF7 \>DLD1. The finding suggested that the cytotoxic effect of umbelliprenin (**1**) is markedly more pronounced in M4Beu cells than in primary fibroblasts and M4Beu cell proliferation is potently inhibited by umbelliprenin (**1**) (IC~50~= 12.3 μM).

Recent studies showed that matrix metallopro-teinases (MMPs) are critical enzymes in tumor growth invasion, metastasis, and neovascularization. In 2006, Iranshahi and coworkers ([@ref13]) reported umbelliprenin (**1**) from *F. persica* as a potent MMPs inhibitor \[IC~50~ = 14 µg/ml comparable with IC~50~ value of diclofenac sodium as the reference drug (46 µg/ml)\] together with farnesiferol A (**2**), gummosin (**5**) and badrakemone (**4**) as weak inhibitors of metalloproteinase production by the fibrosarcoma cell line. Furthermore, they described umbelliprenin (**1**), farnesiferol A (**2**), gummosin (**5**) and badrakemone (**4**) as weak cytotoxic agents with IC~50~ values of 51, 37, 53 and 40 µg/ml, respectively. They concluded that umbelliprenin (**1**) is not a potent cytotoxic agent, however, it inhibits MMPs activity (MMP-9) compared to diclofenac sodium.

To reduce the side effects of these drugs many attempts have been conducted for the improvement of drug delivery systems of active compounds. One of the novel drug delivery system is nanoparticles. Khorramizadeh in 2010 ([@ref31]) prepared umbelliprenin (**1**)-coated Fe~3~O~4~ magnetite nanoparticles (MNPs) and evaluated the anti-proliferative effect of this combination *in vitro*. They demonstrated that umbelliprenin (**1**) has moderate anti-proliferative effects with an IC~50~ value of 50 µg/ml. However, the combination of umbelliprenin (**1**) and Fe~3~O~4~ MNPs showed an IC~50~ value of 9 µg/ml. This means that the antiproliferative effect of umbelliprenin (**1**) enhances up to 350%, after coated on Fe~3~O~4~ MNPs. It is possible that Fe~3~O~4~ MNPs may be efficient carriers for natural compounds, by increasing their water-solubility properties ([@ref31]).

Chronic lymphocytic leukemia (CLL) is a kind of cancer that requires innovative new approaches to improve its therapeutic result. Ziai *et al* in 2011 ([@ref32]) showed umbelliprenin (**1**) induces apoptosis in leukemic cells in a dose- and time-dependent manner and that CLL cells are more susceptible to umbelliprenin (**1**), inducing more cell death than normal peripheral blood mononuclear cells. They also studied the induction of apoptosis in Jurkat cells by umbelliprenin (**1**) in the presence of Interleukin 4 (IL-4), which causes resistance to apoptosis in CLL cells. They reported that IL-4 was not able to reduce the apoptotic effect of umbelliprenin (**1**).

In this regard, Gholami *et al* in 2013 ([@ref33]) studied the effect of umbelliprenin (**1**) on Jurkat T-CLL and Raji B-CLL cell lines. They showed that umbelliprenin (**1**) activates intrinsic and extrinsic pathways of apoptosis by the activation of caspases -8 and -9, respectively.

Myeloid cell leukemia 1 (Mcl-1) is one member of the Bcl-2 family proteins that is expressed in various cancer tissues such as CLL ([@ref34]), where its expression is significantly associated with a failure to achieve complete remission following cytotoxic therapy. Gholami and coworkers ([@ref35]) reported that umbelliprenin could inhibit Mcl-1 protein. They concluded that umbelliprenin (**1**) treatment modulates Mcl-1 expression at both the transcriptional and post translational levels.

Antimicrobial properties {#sec2-6}
------------------------

In 2005, Shahverdi *et al* evaluated the antibacterial activities of chloroform and water extracts of *F. persica* roots. While the chloroform extract showed antibacterial activity, the water extract showed no activity. In continuing and completing their research, they isolated and characterized the active component umbelliprenin (**1**) ([@ref36]). This coumarin at a concentration of 500 µg/ml showed its highest activity against *Bacillus subtillis*, *Bacillus cereus*, *Escherichia coli*, *Klebsiella ponumoniae*, *Salmonella* *typhy*, *Staphylococcus aureus*, and *Staphylococcus* *epidermilis*. Umbelliprenin also showed an anti-pigmentation effect on *Serratia marcescens*. *S. marcescens* is a Gram-negative bacterium that causes diseases in plants and animal hosts. Environmental *S. marcescens* strains are often red, due to the presence of prodigiosin. It is well known that there are some antibiotics affecting pigmentation in bacteria. In 2004, Iranshahi *et al* ([@ref15]) showed umbelliprenin (**1**) to be effective on depigmentation of *S. marcesens*. The bleaching effect of umbelliprenin (**1**) was concentration dependent for *S. marcescens*. The highest concentration tested was 1.5 µmol, whereas a bleaching effect was observed at 0.6 µmol concentration of umbelliprenin (**1**). In that study, umbelliprenin (**1**) showed no antibacterial activity against the test strain at concentrations tested ([@ref15]). In another study, Shahverdi *et al* ([@ref37]) investigated the effect of the other coumarins extracted from *F. persica* roots for depigmentation of *S. marcescens*. None of these compounds appeared to have a bleaching effect against a test strain at concentrations tested. They concluded that the linear umbelliprenin structure may be essential for the bleaching effect in *S. marcescens*.

The antifungal activities of chloroform extracts of *F. persica* roots were also studied using conventional disk diffusion method by Mirjani R. *et al* in 2005 ([@ref38]). They identified persicasulfide A (**8**) and persicasulfide B (**9**) as the most potent antifungal activity with the minimum inhibitory concentrations (MICs) of ≤ 62.5 mg/ml against filamentous fungi.

The first antileishmanial tests on sesquiterpene coumarins were performed in 2007, by Iranshahi *et al* ([@ref33]). They found that umbelliprenin (**1**) and galbanic acid have inhibitory activities against promastigotes of *Leishmania major* after an incubation interval of 48 hr. Their results revealed that umbelliprenin **(1)** inhibit the growth of *L. major* promastigotes with an IC~50~ value of 17.1 µM ([@ref39]).

Cancer chemopreventive effect {#sec2-7}
-----------------------------

It should be noted, however, sesquiterpene coumarins and the other constituents of *F. persica* also possess cancer chemopreventive and antigeno-toxic properties. For example, Soltani *et al* ([@ref40]) tested the protective properties of umbelliprenin (**1**), on the human lymphocytes DNA lesions in 2008. Umbelliprenin (**1**) exhibited a concentration-dependent increase in the protective activity against DNA damage induced by 25 μM H~2~O~2~ (from 67.28% to 39.17%). They also showed the anti-genotoxic activity of ascorbic acid, in the range 0--50 μM, to be greater than that of umbelliprenin (**1**). However, no significant difference (*P*\>0.05) in the protective activity was found between umbelliprenin (**1**) and ascorbic acid at concentrations higher than 50 μM. In addtition, Noroozi *et al* ([@ref41]) reported that the antigenotoxic effect of persicasulfide A (**8**) from *F. persica* on DNA damage that is induced by hydrogen peroxide (H~2~O~2~). In this report, the degree of damage to DNA after exposure to persicasulfide A (**8**) and ascorbic acid in the presence of H~2~O~2~ was calculated based on the amount of DNA present in the tail compared to the total amounts of lymphocyte DNA. They stated that PSA (**8**) does not show genotoxicity causing a 50% reduction in DNA damage induced by H~2~O~2~ (EC~50~:476.47 µM). Compared to the EC~50~ of ascorbic acid (1399.23 µM), persicasulfide A (**8**) was more effective than ascorbic acid in the prevention of oxidative damage to DNA ([@ref41]).

Iranshahi *et al* in 2008 ([@ref23]) carried out a primary screening test of ten terpenoid coumarins isolated from plants of the *Ferula* species, examining their possible inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol 13-acetate (TPA) in Raji cells. Umbelliprenin (**1**) significantly inhibited EBV-EA activation along with preserving the high viability of Raji cells, suggesting that it is a valuable anti-tumor-promoting agents (IC~50~ 9.1 nM). They concluded that the presence of a prenyl moiety in the terpenoid coumarins plays an important role in their anti-tumor promoting activity.

In an *in vivo* study by Iranshahi *et al* ([@ref25]) umbelliprenin (**1**) was reported to be a valuable cancer chemopreventive agent. Their findings showed a reduction in the number of skin tumors per mouse by 45% by umbelliprenin after 20 weeks of promotion compared to the control group. Interestingly, this was equal to the corresponding value (45%) for curcumin, used as a reference standard compound in their study. In addition, the pattern of tumor promotion was slower in mice treated with umbelliprenin (**1**) compared with the curcumin.

Reversal of multi-drug resistance {#sec2-8}
---------------------------------

One of the main molecular mechanisms involved in failure of chemotherapy is multi-drug resistance (MDR). The inhibition of the function of p-glycoprotein (P-gp) in the MDR tumor cells by co-administration of transporter inhibitors and the anticancer agents is a useful strategy to reverse the transporter-mediated MDR ([@ref42]).

Hanafi-Bojd *et al* in 2010 ([@ref17]) investigated the effects of farnesiferol A (**2**) (from the roots of *F. persica*) on the functionality of the drug transporter P-gp using a rhodamine 123 efflux assay in a doxorubicin resistant breast cancer cell line (MCF7/Adr). The inhibition of the P-gp transporter by farnesiferol A (**2**) (0.5 µg/ml) was more potent than that of verapamil (the well-known inhibitor of P-gp) at 15 min exposure.

Recently Kasaian *et al* ([@ref16]) investigated fifteen sesquiterpene coumarins which were isolated and purified from different *Ferula* species, and were tested for their MDR reversal properties. They showed enhancement of doxorubicin cytotoxicity in MCF-7/Adr cells (doxorubicin resistant derivatives of MCF-7 cells overexpressing P-gp) when combined with very non-toxic concentrations of the sesquiterpene coumarins (50 μM) including umbelliprenin (**1**), farnesiferol B (**3**), farnesiferol C and lehmferin, proving the significant MDR reversal activity of these coumarins.

Anti-inflammatory and lipoxygenase inhibitory activity {#sec2-9}
------------------------------------------------------

Inhibition of lipoxygenase is beneficial in the treatment of various diseases including asthma, chronic obstructive pulmonary disease (COPD), osteoporosis and atherosclerosis. Agents that block lipoxygenase catalyzed activity may be effective in preventing cancer by interfering in signaling events needed for tumor growth ([@ref12]). In 2009, anti-inflammatory and lipoxygenase inhibitory activity of umbelliprenin (**1**) in its synthetic form was reported by Iranshahi *et al* ([@ref12]). Preliminarily, umbelliprenin (**1**) was tested for its lipoxygenase inhibitory activity (lipoxygenases are a family of iron containing enzymes that convert arachidonic acid in membrane phospholipids into leukotriene pro-inflammatory mediators) ([@ref43]). Iranshahi and coworkers reported that umbelliprenin (**1**) has a significant inhibitory activity against soybean lipoxygenase with an IC~50~ value of 0.0725 µM. In the second round of the test, the anti-inflammatory activity of umbelliprenin (**1**) was evaluated in *in vivo* on carrageenan mouse paw edema as a clinical model for inflammation. Again, umbelliprenin (**1**) inhibited the inflammation process up to 39% (compared to 47% in indomethacin as a reference control) ([@ref24]). Iranshahi *et al* in 2012 ([@ref44]) synthesized all the mono isopentenyloxy, -geranyloxy and -farnesyloxy derivatives of coumarin and determined their inhibitory potency against soybean 15-lipoxygenase (SLO) and human 15-lipoxygenase-1 (HLO-1). Amongst the synthetic derivatives, 5-farnesyloxycoumarin exhibited the most potent inhibitory activity against SLO (IC~50~ = 0.8 μM) while 6-farnesyloxycoumarin was the strongest HLO-1 inhibitor (IC~50~ = 1.3 μM). The IC~50~ variations of the farnesyl analogs for HLO-1 (1.3 to ∼75 μM) were much higher than those observed for SLO (0.8--5.8 μM).

It may be concluded that the coumarin umbelliprenin and some flavonoids including luteolin 7-O-glucoside that are present in *F. persica* play antioxidant and anti-inflammatory roles.

Miscellaneous activities {#sec2-10}
------------------------

Inhibition of acetyl cholinesterase (AChE) is currently regarded as the leading strategy against Alzheimer's disease. In 2010, Karimi *et al* ([@ref45]) reported the inhibitory activities of 10 naturally occurring terpenoid and coumarin derivatives against human erythrocyte AChE for determining the rate of hydrolysis of acetyl thiochoine in comparison to the reference compound galanthamine, using the modified method of Ellman *et al* ([@ref46]). In this report, farnesiferol A (**2**) and umbelliprenin (**1**) inhibits AChE 20.6% and 17.5%, respectively. However, it should be pointed out that these activities are not comparable to that of the reference inhibitor compound (Galantamine 86.4%).

*F. persica* has been used in traditional medicine for treatment of high blood pressure. Ghanbari *et al* ([@ref47]) investigated the acute and chronic effect of aqueous *F. persica* extract on blood pressure (BP) of hypertensive rats. They showed the intravenous administration of *F. persica* reduces BP of hypertensive rats (*P*\<0.001), but chronic administration of *F. persica* has no effect on BP.

Neuropathic Pain (NP) is caused by cancer, diabetes mellitus, Parkinson's disease and Alzheimer's disease. About 10-30% of patients suffering from syndromes of NP are drug resistant. There is remarkable need for novel analgesic being more effective or safer. Hashemzaei *et al* recently ([@ref48]) evaluated acute and neuropathic pain, using hot-plate, formalin and morphine tests. Their results indicated that the administration of a single dose of umbelliprenin (0.01 Mm) significantly reduces neuropathic pain (*P*\<0.05) compared to the negative control while not changing acute pain against diclofenac. Their research indicates that umbelliprenin (**1**) alone reduces neuropathic pain while its combination with morphine potentiates morphine effects ([@ref48]).

Discussion and concluding remarks {#sec1-2}
=================================

*F. persica* is native to central Asia, particularly Eastern Iran and Afghanistan. The plant has been used in traditional medicine for various purposes. New pharmacological studies have almost confirmed the traditional uses of *F. persica* as an antispasmodic, antibacterial and anti-hypertensive. In addition, there is a correlation between some traditional uses of *F. persica* and those of new studies. *F. persica* is a strong background in traditional medicine for the treatment of diabetes, however, this activity has not been evaluated to date. The authors strongly recommend that the future research is focused on anti-diabetic effects of *F. persica*.

As reported in this paper. umbelliprenin (**1**) is one of the most interesting bioactive constituents from the genus *Ferula*. It is the first sesquiterpene coumarin that is synthesized in the plant *F. persica*. The most interesting properties of umbelliprenin (**1**) were its anti-inflammatory and cancer chemopre-ventive activities ([@ref24]). Different mechanisms seem to play in this activity including lipoxygenase inhibitory property. The lipoxygenase inhibitory effect by umbelliprenin (**1**) and its derivatives increase in the presence of endogenous antioxidants and by reduction of oxidative parameters. Blocking the 5-lipoxygenase enzyme may be a plausible mechanism accounting for at least part of the observed chemo- preventive activity of umbelliprenin (**1**). It reduces the formation of lipoxygenase-carcinogenic products. We have also found that the cancer chemoprevention of umbelliprenin (**1**) is comparable with curcumin, a well-known cancer chemopreventive agent ([@ref25]). In a study, Shahverdi *et al* ([@ref13]) showed umbelliprenin (**1**) as a potent matrix metalloproteinase (MMP) inhibitor. The cytotoxicity of umbelliprenin (**1**) has been found to be related to the presence of the aliphatic sesquiterpenoid group linked at C~7~-OH. Another reported activity of umbelliprenin is its anti-proliferative effect ([@ref44]). This effect of umbelliprenin (**1**) enhances up to 350% when coated on the surface of Fe~3~O~4~ MNPs. This compound by altering their water-solubility properties, be an efficient carrier for natural compounds and lower amounts of these substances may be needed therefore reduce the potential hazards of using metallic nanoparticles. As noted above, umbelliprenin is not cytotoxic on all cell lines. Jurkat T-CLL, Raji B-CLL and M4Beu cell lines are more sensitive to this compound. Gholami *et al* also demonstrated that umbelliprenin (**1**) activates the intrinsic and extrinsic pathways of apoptosis by the activation of caspase-8 and -9, respectively. In addition, umbelliprenin (**1**) inhibits the Mcl-1 protein. They concluded that umbelliprenin treatment modulates Mcl-1 expression at both the transcriptional and post-translational levels ([@ref49]).

One of the main molecular mechanisms involved in the failure of chemotherapy is multi-drug resistance (MDR). Kasaian *et al* ([@ref16]) showed the enhancement of doxorubicin cytotoxicity in MCF-7/Adr cells, when combined with non-toxic concentrations of the sesquiterpene coumarins (50 μM) including umbelliprenin (**1**), farnesiferol B (**3**), farnesiferol C that exhibited significant MDR reversal activity.

Noroozi *et al* reported the anti-genotoxic effect of persicasulfide A (**8**) on DNA damage induced by H~2~O~2~, and persicasulfide A (**8**) was more effective than ascorbic acid in the prevention of oxidative damage to DNA. It is probable that persicasulfide A (**8**) interacts with thiol-containing proteins and alters the activation and metabolism of some genotoxins ([@ref41]).

It is strongly believed that detailed information on the phytochemical and biological activities of *F. persica*, as presented in this review, provides certain evidence for the use of this plant in different medicines. Furthermore, it seems that umbelliprenin (**1**), as a prenylated coumarin, showed various biological activities and it seems that umbelliprenin (**1**) might be a leading compound for designing and synthesizing new derivatives with higher potency and more safety. On the basis of 12 year work on the genus *Ferula* and the plant *F. persica*, the authors strongly recommend to focus future research on anti-diabetic and anti-viral activities of the plant and its sesquiterpene coumarins.
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